Inhibrx Biosciences (INBX) - Wutah bathi EPS kuartalan

Simbol resmi perusahaan Inhibrx Biosciences, Inc. (INBX)

Inhibrx Biosciences (INBX) business is shielded from macroeconomic downturns, as demand for oncology drugs remains stable. However, stringent FDA oversight and costly clinical trials create significant barriers to entry. This quarterly EPS chart, where the -8.00 parameter determines the metric's value, confirms a high level of scientific confidence in the company's assets among major institutional investors.

Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Inhibrx Biosciences, Inc. (INBX): kanggo periode 04.07.2022 - 16.11.2026

Rincian analitis perusahaan Inhibrx Biosciences

Analisis fundamental perusahaan:inhibrx.com, INBX
Produk asil prodhuksi Inhibrx Corp

An issuer's long-term reliability is determined by the stability of its earnings per share generation. This indicator tracks the daily dynamics of quarterly EPS changes, excluding temporary data gaps. By analyzing the quarterly growth slice of EPS, an investor sees the current value of -8.00, which allows for the timely recognition of a value trap. For Inhibrx Biosciences (INBX), given its lack of commercial products, such volatility confirms a dependence on external financing.

Analisis perusahaan pesaing

Incyte Corporation (INCY) - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan HUTCHMED Corp|NUVB (nuvationbio.com) - Wutah bathi EPS kuartalan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan dayonebio.com (DAWN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Monopar Corp (MNPR)|IMAB - Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Fennec Pharmaceuticals Inc FENC|Heron Therapeutics - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|NVCT - Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan coherus.com|CRBP: Wutah bathi EPS kuartalan|Wutah bathi resik saben saham sajroning taun lumaku Cardiff Oncology, Inc. CRDF|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan BYSI|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan BioAtla BCAB|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan LIXT (Lixte Biotechnology)|CTXR (Citius Pharma) - Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Cellectar Biosciences - Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Kacepetan wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan BLRX (BioLineRx)|Can-Fite BioPharma, Ltd. - Wutah bathi EPS kuartalan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan APRE (aprea.com)|KZIA: Wutah bathi EPS kuartalan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Silexion (SLXN)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan nucana.com|CMRX: Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan CYCC|Wutah bathi EPS kuartalan G1 Therapeutics Inc. (GTHX)|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan Kronos Bio Corp KRON|KTRA (Kintara Therapeutics, Inc.) - Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan|ONCT: Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan Portage Biotech Inc